Medartis Holding AG (MDRSF) Stock
Medartis Holding AG is a Switzerland-based medical technology firm, founded in 1997 and headquartered in Basel. The company specializes in the global creation, production, and distribution of advanced implant solutions.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Medartis Holding AG
Medartis Holding AG is a Switzerland-based medical technology firm, founded in 1997 and headquartered in Basel. The company specializes in the global creation, production, and distribution of advanced implant solutions. These sophisticated medical devices are engineered to support the surgical repair and stabilization of bone fractures, specifically targeting injuries in both upper and lower limbs, as well as intricate cranio-maxillofacial surgeries. Operating under its prominent APTUS and MODUS brands, Medartis provides a comprehensive array of osteosynthesis instruments. These specialized tools and implants are designed for a wide spectrum of anatomical applications, including procedures involving the hand, wrist, elbow, shoulder, foot, and ankle, alongside the mandible, midface, orthognathic, and cranial regions. Medartis serves a diverse international client base, including surgeons, hospitals, medical centers, and various group purchasing organizations.
Medartis Holding AG is headquartered in CH.
Medartis Holding AG (MDRSF) stock trades at $115.00 with a market capitalization of $1.43B. The stock is valued at a price-to-earnings (P/E) ratio of 130.60, price-to-book of 3.94, price-to-sales of 4.04. Over the past 52 weeks the stock has ranged between $66.68 and $115.00, and currently trades at its 52-week high.
On profitability, Medartis Holding AG generates a return on equity (ROE) of 3.11%, return on capital employed of 0.24%, an operating margin of 0.42%, a net profit margin of 3.10%.
Official website: www.medartis.com